When the diagnosis is cancer, where a patient begins their treatment can make a difference. The Nebraska Medical Center is proud to offer one of the most respected oncology and hematology departments in the country. Patients across the United States and around the world visit The Nebraska Medical Center to receive innovative treatment from some of the top specialists in the world.
Patients who begin cancer treatment at The Nebraska Medical Center, start their treatment in a place where renowned specialists in specific kinds of cancer work together and focus on each patient's best possible outcome. The care recieved at The Nebraska Medical Center extends far beyond actual cancer treatment. The Survivorship Program is in place to help transition survivors back into the standard health care system and return to their primary physicians. Innovative treatments and a multi-diciplinary approach to care has earned The Nebraska Medical Center prestigious recognition.
With the search for new and innovative treatments, our primary focus is people. Our healthcare providers and all of our employees put our patients and their families first- treating them with warmth and compassion. The Nebraska Medical Center specialists realize cancer is a life changing experience.
U.S. News & World Report's 2008 publication has named The Nebraska Medical Center as one of America's best hospitals for cancer care. In the list of America's Best Hospitals for cancer care, The Nebraska Medical Center ranked 39th. "This cancer ranking confirms our commitment to cancer patients and we are humbled by the recognition," added Franco. "However, this recognition does not mean we will stop striving to be better in the care delivered everyday. We take the journey to excellence very seriously."Read more
The Nebraska Medical Center is the first hospital in the state to receive the Blue
Cross and Blue Shield of Nebraska, Blue Distinction Center for Complex and Rare
Cancers. Only 88 other medical centers in the United States have earned the same
distinction. Blue Distinction Centers for Complex and Rare Cancers were developed
in strategic collaboration with the National Comprehensive Cancer Network (NCCN)
and input from a panel of leading clinicians and professional organizations.
Read more
